Cobalamin (vitamin B12) and holotranscobalamin changes in plasma and liver tissue in alcoholics with liver disease

被引:59
作者
Baker, H
Leevy, CB
DeAngelis, B
Frank, O
Baker, ER
机构
[1] UMDNJ, New Jersey Med Sch, Dept Prevent Med & Community Hlth, Newark, NJ 07107 USA
[2] UMDNJ, New Jersey Med Sch, Dept Med, Newark, NJ 07107 USA
[3] UMDNJ, New Jersey Med Sch, Ctr Liver, Newark, NJ 07107 USA
关键词
vitamin B-12; holotranscobalamins; liver disease;
D O I
10.1080/07315724.1998.10718752
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Objective: We wanted to know if alterations in plasma cobalamin (B-12) concentration and B-12 carriers, e.g., holotranscobalamins (holo TC), occur in blood and liver tissue from patients with severe alcoholic liver disease. Our purpose was to test the hypothesis that liver disease may disrupt B-12 distribution. Method: Total B-12, as well as B-12 bound to transcobalamin I, II, III (holo TC), were measured to determine their concentration in plasma and in liver tissue; Poteriochromonas malhamensis-a protozoan reagent served to measure only metabolically active (true) B-12. Total B-12 as distributed in hero TC in plasma and liver tissue of healthy subjects (controls) were compared to patients with severe alcoholic liver disease. Results: Severe liver disease initiates highly elevated B-12, levels in plasma and a lowered liver tissue total B-12 concentration. The percent of B-12 distributed to hole TC II is significantly depleted during liver disease. In contrast, hole TC I and III are elevated in plasma during liver disease and contain more B-12 than controls. Total B-12 and B-12 distributed to TC are lower in diseased liver tissue. Conclusion: Severe alcoholic liver disease involves leakage of total B-12 from liver tissue into the plasma. Hole TC I and III concentration increases in plasma; this preserves the high plasma B-12 from being excreted. However, plasma holo TC II B-12 distribution is decreased, indicating that there is a depression of exogenous B-12 entering the plasma and tissues. In severe liver disease, liver tissue B-12 binding and storage by TC is disrupted and causes B-12 to leak out of the liver into the circulation. Eventually liver disease could produce enough severe tissue B-12 deficits to cause metabolic dysfunction despite elevated plasma total B-12. Elevation of plasma B-12, accompanied by a lowering of hole TC II distribution, seemed to be a useful index of liver disease severity suggesting preventative treatment.
引用
收藏
页码:235 / 238
页数:4
相关论文
共 22 条
[1]   Holotranscobalamins in B-12 and non B-12 requiring prokaryotes and eukaryotes [J].
Baker, H ;
DeAngelis, B ;
Khalil, M ;
Frank, O ;
Baker, ER .
COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY B-BIOCHEMISTRY & MOLECULAR BIOLOGY, 1996, 113 (04) :707-709
[2]  
BAKER H, 1986, J AM COLL NUTR, V5, P467
[3]  
BAKER H, 1987, ALCOHOL ALCOHOLISM, V22, P1
[4]  
BAKER H, 1964, AM J CLIN NUTR, V14, P1, DOI 10.1093/ajcn/14.1.1
[5]  
BAKER H, 1958, CLIN CHEM, V4, P27
[6]  
BAKER H, 1956, CLIN CHEM, V2, P328
[7]  
BAKER H, 1968, CLIN VITAMINOLOGY ME, P116
[8]  
BAKER H, 1980, MODERN NUTRITION HLT, P611
[9]  
CARMEL R, 1981, CONT HEMATOLOGY ONCO, V2, P79
[10]   EVIDENCE THAT SOME PATIENTS WITH PERNICIOUS-ANEMIA ARE NOT RECOGNIZED BY RADIODILUTION ASSAY FOR COBALAMIN IN SERUM [J].
COOPER, BA ;
WHITEHEAD, VM .
NEW ENGLAND JOURNAL OF MEDICINE, 1978, 299 (15) :816-818